Rezolute, Inc.(RZLT)Stock Analysis
AI analysis on 2,800+ stocks →Deep AI analysis on 2,800+ stocks →13F Pro Quality Score
Not in ranked universe
Below size threshold
Below the main board's size threshold of $25M annual revenue or $100M total assets. This company reported $0.0M in revenue and is scored on the micro-cap board instead.
Financial data, filings, and institutional holdings below are still tracked in full — only the proprietary quality composite is unavailable for this name.
RZLT Stock Analysis & AI Quality Score
Data updated 2026-07-26AI stock analysis and institutional research for Rezolute, Inc. (RZLT), a Healthcare sector company. RZLT is not currently included in 13F Pro's AI-ranked quality universe — below the main board's size threshold of $25m annual revenue or $100m total assets. this company reported $0.0m in revenue and is scored on the micro-cap board instead. Top institutional holders of RZLT by reported 13-F value include FEDERATED HERMES, RA CAPITAL MANAGEMENT, L.P., BlackRock, based on the most recent SEC filings. RZLT trades on the Nasdaq exchange and files with the SEC under CIK 1509261. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate RZLT daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for Rezolute, Inc. directly from SEC EDGAR.
Net Income
Q1 2026
$-16.2M
ROIC
Q1 2026
-59.5%
Revenue & Net Income
Earnings Per Share
Key Financials Over Time
Export Financial Table · ProNet Income
-8.7% YoYOperating Income
-13.4% YoYEPS (Diluted)
+26.3% YoYTotal Assets
+32.2% YoYTotal Debt
Op. Cash Flow
-20.4% YoYFree Cash Flow
| Metric | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Net Income | $-74.4M -8.7% | $-68.5M -32.2% | $-51.8M -26.1% | $-41.1M -96.4% | $-20.9M -2.8% | $-20.3M |
| Operating Income | $-79.9M -13.4% | $-70.4M -25.8% | $-56.0M -33.8% | $-41.8M -82.8% | $-22.9M -11.6% | $-20.5M |
| EPS (Diluted) | $-0.98 +26.3% | $-1.33 -31.7% | $-1.01 +56.5% | $-2.32 +14.7% | $-2.72 | — |
| Total Assets | $175.5M +32.2% | $132.7M +7.3% | $123.7M -18.8% | $152.4M +257.7% | $42.6M +288.6% | $11.0M |
| Total Debt | — | — | — | — | $14.0M | $0.00 |
| Operating Cash Flow | $-69.1M -20.4% | $-57.4M -29.0% | $-44.5M -12.3% | $-39.6M -93.8% | $-20.4M +15.4% | $-24.2M |
| Free Cash Flow | — | — | $-44.6M | — | — | $-24.2M |
Get alerted when RZLT's score changes
Free account: watchlist tracking, the daily AI brief, and the AI screener.
Available Research
13F Pro tracks comprehensive data for Rezolute, Inc. including:
Top Institutional Holders of RZLT
FEDERATED HERMES, INC.
$67.6M12,990,659 shRA CAPITAL MANAGEMENT, L.P.
$49.1M9,445,039 shBlackRock, Inc.
$40.1M7,718,291 shOpaleye Management Inc.
$32.8M6,300,000 shBALYASNY ASSET MANAGEMENT L.P.
$24.2M4,662,039 shVANGUARD CAPITAL MANAGEMENT LLC
$19.9M3,835,827 shSiren, L.L.C.
$17.3M3,328,287 shJACOBS LEVY EQUITY MANAGEMENT, INC
$13.3M2,561,654 shJENNISON ASSOCIATES LLC
$12.8M2,459,308 shGEODE CAPITAL MANAGEMENT, LLC
$11.3M2,170,154 sh
| Fund | Value | Shares |
|---|---|---|
| FEDERATED HERMES, INC. | $67.6M | 12,990,659 |
| RA CAPITAL MANAGEMENT, L.P. | $49.1M | 9,445,039 |
| BlackRock, Inc. | $40.1M | 7,718,291 |
| Opaleye Management Inc. | $32.8M | 6,300,000 |
| BALYASNY ASSET MANAGEMENT L.P. | $24.2M | 4,662,039 |
| VANGUARD CAPITAL MANAGEMENT LLC | $19.9M | 3,835,827 |
| Siren, L.L.C. | $17.3M | 3,328,287 |
| JACOBS LEVY EQUITY MANAGEMENT, INC | $13.3M | 2,561,654 |
| JENNISON ASSOCIATES LLC | $12.8M | 2,459,308 |
| GEODE CAPITAL MANAGEMENT, LLC | $11.3M | 2,170,154 |
More Healthcare Companies
View all Healthcare →Put RZLT on your watchlist
Track score changes the day Rezolute, Inc. files with the SEC, follow the hedge funds that own it, screen 2,800+ AI-scored stocks, and get the daily brief — free.
Free tier includes 13F data, economic indicators, and market overview. Pro starts at $6.67/mo (billed annually).
Popular Research
Is RZLT a good stock to buy?
13F Pro's AI-powered analysis of Rezolute, Inc. (RZLT) draws on SEC EDGAR-sourced fundamentals, institutional 13F holdings, and insider Form 4 transactions in the Healthcare sector (listed on Nasdaq). The 32-signal AI Quality Score, current rank, and full bull/bear verdict for RZLT are available on the RZLT stock profile dashboard — with the same data, AI insights, ratios, and institutional activity refreshed after every 10-K, 10-Q, 13F, and Form 4 filing. RZLT is classified as a small company.
Which hedge funds own RZLT?
Institutional investors are required to disclose their holdings quarterly via SEC Form 13F. 13F Pro aggregates these filings to show which hedge funds, mutual funds, and asset managers are buying or selling RZLT. Combined with insider transaction data from Form 4 filings and AI-powered analysis from 10 specialized research agents, 13F Pro provides a comprehensive view of Rezolute, Inc.'s investment landscape.